Viewing Study NCT00426556

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:21 PM
Ignite Modification Date: 2025-12-31 @ 10:09 PM
Study NCT ID: NCT00426556
Status: COMPLETED
Last Update Posted: 2015-12-28
First Post: 2007-01-23
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Breast cancer View
None Cancer of the breast View
None Human mammary carcinoma View
None HER-2 View
None Metastatic View
None everolimus View
None trastuzumab View
None paclitaxel View